Aurobindo Pharma inks pact with New Mountain Capital to sell US-based unit for USD 550 mn

The drug firm has reached a definitive agreement to sell Natrol, a unit of Aurobindo Pharma USA, Inc, to an affiliate of New Mountain Capital to combine with Jarrow Formulas, Aurobindo Pharma said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dZ1E0v
via IFTTT